Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Keratosis, Actinic 39Melanosis 3Carcinoma, Basal Cell 3Warts 1Keratosis, Seborrheic 1Keratosis 1Facies 1Condylomata Acuminata 1Carcinoma, Squamous Cell 1Carcinoma 1Bowen's Disease 1

Interventions

Imiquimod 3tirbanibulin 2Ointments 1Fluorouracil 1BF-200 ALA 13-ingenyl angelate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Keratosis × 3-ingenyl angelate × Clear all
NCT00239135 2015-03-25

Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel

Peplin

Phase 2 Completed
34 enrolled
Dermatologic

Keratosis, Melanosis, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡